TCGX TCGX Acquisition Corp.
$10.14▲ +0.40%
Financials
Other
Volume 88.2K
Avg Volume (10D) 404.4K
Key Metrics & Fundamentals
Market Cap
$114.62M
P/E Ratio
–
Div Yield
0.00%
52W Range
9.90 - 18.91
% vs 50 MA
-22.85%
% vs 200 MA
–%
RSI-14
31.1
MACD Histogram
-0.2100
Beta (1Y vs SPY)
0.34
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
TriGemX Bio to Go Public Through TCGX SPAC Merger
MT Newswires · Oct 19, 2026 7:43 AM ET
TriGemX Bio and TCGX Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Company to Develop Elismetrep, a Potential First-in-Class Treatment for Migraine
Business Wire · Oct 19, 2026 7:00 AM ET
TriGemX Bio and TCGX Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Company to Develop Elismetrep, A Potential First-in-Class Treatment for Migraine
Business Wire · Oct 19, 2026 7:00 AM ET
TCGX Acquisition Corp. II Announces Pricing of $100,000,000 Initial Public Offering
Business Wire · Oct 15, 2026 5:13 PM ET
TCGX Acquisition Corp. Announces Completion of its Initial Public Offering
Business Wire · Aug 6, 2026 4:05 PM ET
TCGX Acquisition Corp. Announces Pricing of $75,000,000 Initial Public Offering
Business Wire · Aug 4, 2026 7:10 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.